Material Type

• Buffy coat (1)
• Cerebrospinal fluid (1)
• Dried whole blood (2)
• Plasma (double spun) (1)
• Plasma (single spun) (3)
• Saliva (1)
• Serum (3)
• Swab medium (1)
• Urine (first morning) (1)
• Urine (random) (1)

Microscopic Assessment

• Affected (1)
• Non-affected (2)
• Not applicable (5)

Storage Temperature

• RT (1)
• -35°C to -18°C (2)
• -85°C to -60°C (4)

Associated Data

• Biomarker datasets (3)
• Clinical records (5)
• Followup records (3)
• Freezer temperature logs (4)
• Genomic datasets (1)
• Microbiological results (2)
• Participant Ethnicity (3)
• Pre-analytical data (1)
• Quality indicators (2)
• Survey data (3)
• Treatment records (3)

Timeframe

• Immediate (4)
• 0 - 3 months (5)
• 3 - 6 months (2)
• > 6 months (1)

Participant Count

• 11 - 100 (7)

Sex

• Unknown (1)
• Both sexes (6)

Age Range

• Child (6 - 12 years) (2)
• Adolescent (12 - 18 years) (3)
• Young adult (18 - 40 years) (4)
• Adult (> 40 years) (3)

Biobank Services

• Data analytics (1)
• Digital imaging (1)
• Nucleic acid extraction (1)

Collection Type

• Case-control (2)
• Clinical Trial (1)
• Disease specific (4)
• Longitudinal (1)

Consent Restriction

• No Commercial restriction (4)
• No Disease area restriction (7)
• No Genetic analysis restriction (2)
• No Human genetic analysis restriction (3)
• No restrictions (1)
• No Project specific restriction (7)
• No Scope of use restriction (6)

Collection Status

• Completed (7)

Access Condition

• Open to applicants (5)
• Open only through collaboration (1)
• Closed to access (1)

Country

• Belgium (1)
• France (1)
• Ghana (1)
• Kenya (2)
• United Kingdom of Great Britain and Northern Ireland (1)
• United States (1)

County